MIT BOTULINUMTOXIN VORGEFÜLLTES SPRITZENSYSTEM

European patent · EP3474931 · In force

Register entry

Publication number
EP3474931
Application number
EP17733769
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 20, 2017
Published
May 1, 2019
Granted
Sep 24, 2025
Protection ends at the latest
Jun 19, 2037
Next annual fee due
Jun 30, 2027
IPC classes
A61M 5/315 (2006.01)
A61M 5/178 (2006.01)
Priority
EP 16001404 22.06.2016
PCT application
PCT/EP2017/065050 20.06.2017
PCT publication
WO2017/220553 28.12.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 5, 2026

    Change

    Published in Swissreg on 05.08.2026

  2. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  3. Sep 24, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 24.09.2025

Parties

Holder

Merz Pharma GmbH & Co. KGaA

Eckenheimer Landstrasse 100, 60318 Frankfurt am Main, DE

Inventor

VOGT, Markus

60438 Frankfurt am Main, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.